Cordant Inc’s Ingevity NGVT Stock Holding History

Cordant Inc’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14	Closed	-$1K	–	842
2022 Q1	$1K	Buy	+14	New	+$937	﹤0.01%	1032

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICP

Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

Cordant Inc's NGVT Position: Q2 2022 in Review

Cordant Inc sold out of Ingevity (NGVT) in Q2 2022, closing a stake of 14 shares — an estimated $1K sold.

Cordant Inc first reported a position in NGVT in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 265 funds tracked by Wall St. Rank hold NGVT as of Q2 2022.

Cordant Inc reported no remaining Ingevity position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 14 Ingevity shares in Q2 2022, an estimated $1K.
Cordant Inc first reported a position in Ingevity in Q1 2022 and held it in 1 quarter.
Cordant Inc's Ingevity position peaked at $1K in Q1 2022.
265 funds tracked by Wall St. Rank held Ingevity as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.